Replies to post #104893 on Biotech Values

[DewDiligence]

From GSK’s PR:

As a result of the regulatory updates in both the US and EU, GSK now expects global sales of Avandia products to be in a range of approximately 100m pounds Sterling - 150m pounds Sterling in the second half of 2010 and with minimal annual sales thereafter.

http://finance.yahoo.com/news/GSK-Regulatory-Update-on-prnews-4008904803.html?x=0&.v=1